Edwards Lifesciences Aktie

Kaufen
Verkaufen
67,01 EUR +1,35 EUR +2,06 %
72,46 USD +1,57 USD +2,21 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 38,36 Mrd. EUR

KGV 50,73 Div. Rendite 0,00%

WKN 936853

ISIN US28176E1082

Symbol EW


Edwards Lifesciences Aktie Analyse

17.11.09 Edwards Lifesciences overweight Barclays Capital
29.10.09 Edwards Lifesciences buy Goldman Sachs Group Inc.
25.09.09 Edwards Lifesciences buy UBS AG
01.09.09 Edwards Lifesciences outperform Credit Suisse Group
22.07.09 Edwards Lifesciences outperform Credit Suisse Group
26.02.09 Edwards Lifesciences outperform RBC Capital Markets
24.02.09 Edwards Lifesciences outperform Credit Suisse Group
07.11.08 Edwards Lifesciences buy Piper Jaffray & Co.
24.07.08 Edwards Lifesciences buy Stanford Financial Group, Inc.
10.06.08 Edwards Lifesciences outperform Credit Suisse Group
05.06.08 Edwards Lifesciences buy Stanford Financial Group, Inc.
20.05.08 Edwards Lifesciences outperform Credit Suisse Group
24.04.08 Edwards Lifesciences buy Stanford Financial Group, Inc.
24.04.08 Edwards Lifesciences outperform Credit Suisse Group
18.03.08 Edwards Lifesciences buy Stanford Financial Group, Inc.
10.12.07 Edwards Lifesciences outperform Credit Suisse Group
05.10.07 Edwards Lifesciences outperform Piper Jaffray & Co.
30.04.07 Edwards Lifesciences buy Needham & Co
30.12.05 Edwards Lifesciences buy Needham & Co
15.12.05 Edwards Lifesciences buy Needham & Co
14.12.05 Edwards Lifesciences Buy Needham & Co
09.12.05 Edwards Lifesciences Overweight Prudential Securities
Werbung